University of Maryland, Baltimore;OncoImmune, Inc.
发明人:
LIU, Yang,ZHENG, Pan,TANG, Fei,LIU, Mingyue,DEVENPORT, Martin,DU, Xuexiang,ZHANG, Yan
申请号：
AU2019214865
公开号：
AU2019214865A1
申请日:
2019.01.29
申请国别(地区):
AU
年份:
2020
代理人:
摘要：
This invention relates to anti-CTLA-4 antibody compositions that bind to the human CTLA-4 molecule, and the use of the compositions in cancer immunotherapy and for reducing autoimmune side effects compared to other immunotherapeutic agents.
